Furthermore, very recently, it has been reported that α-MSH administration in mouse models of Alzheimer's disease prevents the GABAergic neuronal loss and thus ameliorates the cognition [47, 52–54]. This evidence concerns the gene STAMBP and Alzheimer disease.